Cite
HARVARD Citation
Metts, J. et al. (2023). A phase I trial of metformin in combination with vincristine, irinotecan, and temozolomide in children with relapsed or refractory solid and central nervous system tumors: A report from the national pediatric cancer foundation. Cancer medicine. pp. 4270-4281. [Online].